Islam Khalid 4
4 · Processa Pharmaceuticals, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Islam Khalid
Director
Transactions
- Award
Common Stock
2022-03-31+4,392→ 72,486 total
Holdings
- 120,909(indirect: by Elion Oncology, Inc.)
Common Stock
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]Shares previously reported as indirectly held by Elion Oncology were transferred to the reporting person's direct holdings in a transaction exempt from Section 16 reporting pursuant to Rule 16a-13.